Patents Assigned to Rhizen Phamaceuticals SA
  • NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL
    Publication number: 20130310377
    Abstract: Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.
    Type: Application
    Filed: December 20, 2012
    Publication date: November 21, 2013
    Applicant: Rhizen Phamaceuticals SA
    Inventor: Rhizen Phamaceuticals SA